Update on Minimally Invasive Glaucoma Surgery (MIGS)‎ and New Implants

Abstract EN

Traditional glaucoma surgery has been challenged by the advent of innovative techniques and new implants in the past few years.

There is an increasing demand for safer glaucoma surgery offering patients a timely surgical solution in reducing intraocular pressure (IOP) and improving their quality of life.

The new procedures and devices aim to lower IOP with a higher safety profile than fistulating surgery (trabeculectomy/drainage tubes) and are collectively termed “minimally invasive glaucoma surgery (MIGS).” The main advantage of MIGS is that they are nonpenetrating and/or bleb-independent procedures, thus avoiding the major complications of fistulating surgery related to blebs and hypotony.

In this review, the clinical results of the latest techniques and devices are presented by their approach, ab interno (trabeculotomy, excimer laser trabeculotomy, trabecular microbypass, suprachoroidal shunt, and intracanalicular scaffold) and ab externo (canaloplasty, Stegmann Canal Expander, suprachoroidal Gold microshunt).

The drawback of MIGS is that some of these procedures produce a limited IOP reduction compared to trabeculectomy.

Currently, MIGS is performed in glaucoma patients with early to moderate disease and preferably in combination with cataract surgery.